AI assistant
CONMED Corp — Director's Dealing 2021
May 6, 2021
31971_dirs_2021-05-06_3f5adcb3-5a8f-4dfb-b00d-08bd24b43355.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-05-05
Reporting Person: Cohen Heather L (EVP CORP HR)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-05 | Common Stock | S | 4017 | $141.673 | Disposed | 25056 | Direct |
| 2021-05-05 | Common Stock | S | 450 | $143.327 | Disposed | 24606 | Direct |
| 2021-05-05 | Common Stock | S | 150 | $144.15 | Disposed | 24456 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.30 to $142.14. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.82 to $143.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.83 to $144.79. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.